GlassScriptPhysician profile
Ross Parker Smith
NPI 1437596293
$4,051.53
in general payments reported to CMS, 2019-2025
13 companies · $884 in 2025
The $884 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,229 · 2020: $91.33 · 2021: $323 · 2022: $41.97 · 2023: $88.16 · 2024: $394 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297 · Education: $68.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.12 |
| Education | $68.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,398.07 | 2019-2025 | Mako, Variax, T2 |
| Synthes Gmbh | $1,306.80 | 2019 | |
| Depuy Synthes Sales INC. | $413.22 | 2019-2025 | Va-Lcp, Na |
| Biocomposites INC | $266.67 | 2023-2025 | Stimulan |
| Sanara Medtech INC. | $208.79 | 2020-2021 | |
| Medical Device Business Services, INC. | $175.77 | 2019 | |
| Si-Bone, INC. | $127.23 | 2021 | |
| Wound Management Technologies, INC | $48.20 | 2019 | |
| Skeletal Dynamics INC | $28.18 | 2024-2025 | Align, Geminus, Implate |
| Djo, LLC | $22.65 | 2023 | Cmf |
| Ossur Americas, INC. | $21.20 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $18.08 | 2023 | Exparel, Iovera, Zilretta |
| Integra Lifesciences Corporation | $16.67 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.